Tower Research Capital (TRC)’s NeuBase Therapeutics, Inc. Common Stock NBSE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q2
Sell
-2,572
Closed -$1.16K 6143
2024
Q1
$1.16K Buy
2,572
+124
+5% +$56 ﹤0.01% 5312
2023
Q4
$1.81K Buy
2,448
+16
+0.7% +$12 ﹤0.01% 5321
2023
Q3
$2.12K Sell
2,432
-5,383
-69% -$4.68K ﹤0.01% 5212
2023
Q2
$14.6K Buy
7,815
+6,926
+779% +$13K ﹤0.01% 3659
2023
Q1
$3K Buy
889
+1
+0.1% +$3 ﹤0.01% 5275
2022
Q4
$3K Buy
888
+245
+38% +$828 ﹤0.01% 5273
2022
Q3
$5K Buy
643
+545
+556% +$4.24K ﹤0.01% 5190
2022
Q2
$2K Sell
98
-506
-84% -$10.3K ﹤0.01% 5639
2022
Q1
$23K Sell
604
-393
-39% -$15K ﹤0.01% 3413
2021
Q4
$56K Buy
997
+926
+1,304% +$52K ﹤0.01% 2687
2021
Q3
$5K Sell
71
-194
-73% -$13.7K ﹤0.01% 4903
2021
Q2
$25K Sell
265
-181
-41% -$17.1K ﹤0.01% 3702
2021
Q1
$66K Buy
446
+166
+59% +$24.6K ﹤0.01% 2900
2020
Q4
$39K Sell
280
-521
-65% -$72.6K ﹤0.01% 3355
2020
Q3
$122K Buy
801
+620
+343% +$94.4K ﹤0.01% 2990
2020
Q2
$32K Buy
+181
New +$32K ﹤0.01% 3407
2017
Q3
Sell
-177
Closed -$45K 4332
2017
Q2
$45K Buy
177
+157
+785% +$39.9K 0.01% 802
2017
Q1
$6K Buy
20
+11
+122% +$3.3K ﹤0.01% 2133
2016
Q4
$5K Buy
+9
New +$5K ﹤0.01% 3088
2016
Q3
Sell
-1
Closed -$1K 4639
2016
Q2
$1K Sell
1
-3
-75% -$3K ﹤0.01% 4243
2016
Q1
$4K Buy
4
+1
+33% +$1K ﹤0.01% 2953
2015
Q4
$7K Buy
+3
New +$7K ﹤0.01% 2639
2015
Q3
Sell
-10
Closed -$10K 5006
2015
Q2
$10K Buy
+10
New +$10K ﹤0.01% 2722
2015
Q1
Sell
-2
Closed -$7K 5072
2014
Q4
$7K Sell
2
-18
-90% -$63K ﹤0.01% 2485
2014
Q3
$57K Buy
20
+14
+233% +$39.9K 0.01% 1428
2014
Q2
$23K Buy
6
+5
+500% +$19.2K ﹤0.01% 1768
2014
Q1
$4K Sell
1
-7
-88% -$28K ﹤0.01% 3483
2013
Q4
$24K Buy
8
+6
+300% +$18K ﹤0.01% 2133
2013
Q3
$7K Buy
2
+1
+100% +$3.5K ﹤0.01% 3471
2013
Q2
$4K Buy
+1
New +$4K ﹤0.01% 3137